Literature DB >> 8288892

Restoration of a normal level of immunoglobulin production in a hybridoma cell line following modification of the chromosomal immunoglobulin mu gene by gene replacement.

M D Baker1, H A Karn, L R Read.   

Abstract

In the present investigation, we have measured the levels of IgM mRNA and protein in recombinant cell lines in which the chromosomal immunoglobulin mu gene has been modified by gene replacement (gene conversion or double reciprocal recombination) or vector integration (single reciprocal recombination) events. Our studies reveal that chromosomal immunoglobulin mu genes modified by gene replacement are expressed at wild-type levels whereas those modified by vector integration have lower levels of immunoglobulin mu gene expression. These results suggest that gene replacement may a preferred method for the construction of hybridoma and myeloma cell lines producing optimized immunoglobulins and for studies of immunoglobulin gene function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288892     DOI: 10.1016/0022-1759(94)90205-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  A strand invasion 3' polymerization intermediate of mammalian homologous recombination.

Authors:  Weiduo Si; Maureen M Mundia; Alissa C Magwood; Adam L Mark; Richard D McCulloch; Mark D Baker
Journal:  Genetics       Date:  2010-03-22       Impact factor: 4.562

2.  Genetic stability of gene targeted immunoglobulin loci. I. Heavy chain isotype exchange induced by a universal gene replacement vector.

Authors:  C Kardinal; M Selmayr; R Mocikat
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

3.  Unaltered immunoglobulin expression in hybridoma cells modified by targeting of the heavy chain locus with an integration vector.

Authors:  R Mocikat; C Kardinal; P Lang; R Zeidler; S Thierfelder
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.